146 related articles for article (PubMed ID: 37286975)
1. Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot.
Stämpfli D; Imfeld-Isenegger TL; Hersberger KE; Messerli M
BMC Infect Dis; 2023 Jun; 23(1):384. PubMed ID: 37286975
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and outcomes of a hepatitis C screening programme in community pharmacies.
Gauld N; Perry J; Jackson C; Gane E
N Z Med J; 2020 Nov; 133(1525):74-83. PubMed ID: 33223550
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
4. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
Dong BJ; Lopez M; Cocohoba J
J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
[TBL] [Abstract][Full Text] [Related]
5. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London.
Baraitser P; Pearce V; Holmes J; Horne N; Boynton PM
Qual Saf Health Care; 2007 Aug; 16(4):303-7. PubMed ID: 17693680
[TBL] [Abstract][Full Text] [Related]
7. Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program.
Klepser DG; Klepser ME; Peters PJ; Hoover KW; Weidle PJ
Prev Chronic Dis; 2022 Dec; 19():E83. PubMed ID: 36480802
[TBL] [Abstract][Full Text] [Related]
8.
Byrne C; Radley A; Inglis SK; Beer LJZ; Palmer N; Pham MD; Healy B; Doyle JS; Donnan P; Dillon JF
BMJ Open; 2020 Aug; 10(8):e036501. PubMed ID: 32868356
[TBL] [Abstract][Full Text] [Related]
9. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).
Januszka J; Notarianni V; Devenny E; Harris E
J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394
[TBL] [Abstract][Full Text] [Related]
10. HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection.
Weidle PJ; Lecher S; Botts LW; Jones L; Spach DH; Alvarez J; Jones R; Thomas V
J Am Pharm Assoc (2003); 2014; 54(5):486-92. PubMed ID: 25216878
[TBL] [Abstract][Full Text] [Related]
11. HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study.
Barror S; Avramovic G; Oprea C; Surey J; Story A; Macías J; Cullen W; Crowley D; Horan A; Naughton AM; Iglesias M; Ianache I; Lazar S; Popa I; McHugh T; Menezes D; Tinago W; Lambert JS
J Antimicrob Chemother; 2019 Nov; 74(Suppl 5):v39-v46. PubMed ID: 31782499
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C screening in a community pharmacy setting: Patient perspective.
Pegump KN; Nichols RE; Polgreen LA; Veach SR; Crowner AB; Witry MJ
J Am Pharm Assoc (2003); 2023; 63(4S):S78-S82. PubMed ID: 36804712
[TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
14. Time and motion study of hepatitis C virus point-of-care testing in community pharmacies.
Beuschel T; Gootee E; Jordan M; Sikkenga T; Klepser DG; Holmquist H; de Voest A; Klepser ME
J Am Pharm Assoc (2003); 2023; 63(1):435-439. PubMed ID: 36463010
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of hepatitis C virus testing and linkage in community supervision offices: Great potential but persistent challenges.
Jacka BP; Bazerman LB; Dickerson C; Moody M; Martin J; Patry E; Cady T; Compere H; Boudreau M; Beckwith CG
Int J Drug Policy; 2022 May; 103():103668. PubMed ID: 35367903
[TBL] [Abstract][Full Text] [Related]
16. The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement.
Cook C; Reid L; Elsharkawy AM; Radley A; Smith S; McPherson S; Crockford D; Dillon JF; Wright M; Morris D; Malik H; Keall S; Powell J; Catt J; Hampton H; Boothman H; Shah S; Spear J; Ustianoski A; John P; Stevens H; Khakoo SI; Parkes J; Buchanan RM
Public Health; 2024 Jul; 232():153-160. PubMed ID: 38781782
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care testing for HCV infection: recent advances and implications for alternative screening.
Parisi MR; Soldini L; Vidoni G; Mabellini C; Belloni T; Brignolo L; Negri S; Schlusnus K; Dorigatti F; Lazzarin A
New Microbiol; 2014 Oct; 37(4):449-57. PubMed ID: 25387283
[TBL] [Abstract][Full Text] [Related]
18. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
[TBL] [Abstract][Full Text] [Related]
19. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
Lebovics E; Torres R; Porter LK
Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
[TBL] [Abstract][Full Text] [Related]
20. Door-to-door hepatitis C screening in Georgia: An innovative model to increase testing and linkage to care.
Butsashvili M; Zurashvili T; Kamkamidze G; Kajaia M; Gulbiani L; Gamezardashvili A; Gvinjilia L; Kuchuloria T; Gamkrelidze A; Shadaker S; Nasrullah M; Averhoff F; Armstrong PA
J Med Screen; 2022 Jun; 29(2):134-136. PubMed ID: 35293802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
